Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial

Cherney, David Z. and Dekkers, Claire C. J. and Barbour, Sean J. and Cattran, Daniel and Gafor, Abdul Halim Abdul and Greasley, Peter J. and Laverman, Gozewijn D. and Lim, Soo Kun and Di Tanna, Gian Luca and Reich, Heather N. and Vervloet, Marc G. and Wong, Muh Geot and Gansevoort, Ron T. and Heerspink, Hiddo J. L. and Investigators, DIAMOND (2020) Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial. Lancet Diabetes & Endocrinology, 8 (7). pp. 582-593. ISSN 2213-8587,

Full text not available from this repository.
Item Type: Article
Funders: Diabetes Australian Research Trust Millennium Grant
Uncontrolled Keywords: SGLT2 inhibitor dapagliflozin; Proteinuria; Non-diabetic patients; Chronic kidney disease
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Medicine Department
Depositing User: Ms Zaharah Ramly
Date Deposited: 09 Feb 2023 07:06
Last Modified: 09 Feb 2023 07:06
URI: http://eprints.um.edu.my/id/eprint/37566

Actions (login required)

View Item View Item
UM Research Repository is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.